168 related articles for article (PubMed ID: 30691793)
1. Unraveling the South African Breast Cancer Story: The Relationship of Patients, Delay to Diagnosis, and Tumor Biology With Stage at Presentation in an Urban Setting.
Rayne S; Schnippel K; Grover S; Fearnhead K; Kruger D; Benn C; Firnhaber C
J Surg Res; 2019 Mar; 235():181-189. PubMed ID: 30691793
[TBL] [Abstract][Full Text] [Related]
2. Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014.
Schroeder MC; Rastogi P; Geyer CE; Miller LD; Thomas A
Oncologist; 2018 Apr; 23(4):481-488. PubMed ID: 29330212
[TBL] [Abstract][Full Text] [Related]
3. Determinants of Advanced Stage at Initial Diagnosis of Breast Cancer in Pakistan: Adverse Tumor Biology vs Delay in Diagnosis.
Khokher S; Qureshi MU; Mahmood S; Sadiq S
Asian Pac J Cancer Prev; 2016; 17(2):759-65. PubMed ID: 26925676
[TBL] [Abstract][Full Text] [Related]
4. Delay to diagnosis and breast cancer stage in an urban South African breast clinic.
Rayne S; Schnippel K; Kruger D; Benn CA; Firnhaber C
S Afr Med J; 2019 Feb; 109(3):159-163. PubMed ID: 30834871
[TBL] [Abstract][Full Text] [Related]
5. What could be the reasons of late diagnosis of breast cancer in Tunisia?
Ben Fatma L; Belaid I; Said N; Gahbiche S; Hochlef M; Chabchoub I; Ezzairi F; Ben Ahmed S
Tunis Med; 2018; 96(10-11):665-671. PubMed ID: 30746659
[TBL] [Abstract][Full Text] [Related]
6. Barriers to early presentation of breast cancer among women in Soweto, South Africa.
Joffe M; Ayeni O; Norris SA; McCormack VA; Ruff P; Das I; Neugut AI; Jacobson JS; Cubasch H
PLoS One; 2018; 13(2):e0192071. PubMed ID: 29394271
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer in young women from a low risk population in Nepal.
Thapa B; Singh Y; Sayami P; Shrestha UK; Sapkota R; Sayami G
Asian Pac J Cancer Prev; 2013; 14(9):5095-9. PubMed ID: 24175782
[TBL] [Abstract][Full Text] [Related]
8. Determinants of Delayed Presentation and Advanced-Stage Diagnosis of Breast Cancer in Africa: A Systematic Review and Meta-Analysis.
Agodirin O; Aremu I; Rahman G; Olatoke S; Olaogun J; Akande H; Romanoff A
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1007-1017. PubMed ID: 33906291
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer biology and ethnic disparities in breast cancer mortality in new zealand: a cohort study.
Seneviratne S; Lawrenson R; Scott N; Kim B; Shirley R; Campbell I
PLoS One; 2015; 10(4):e0123523. PubMed ID: 25849101
[TBL] [Abstract][Full Text] [Related]
10. [Breast cancer in Sub-Saharan African women: review].
Ly M; Antoine M; André F; Callard P; Bernaudin JF; Diallo DA
Bull Cancer; 2011 Jul; 98(7):797-806. PubMed ID: 21700549
[TBL] [Abstract][Full Text] [Related]
11. Profile of molecular subtyping of breast cancer and clinicopathological features in Mankweng Hospital breast oncology clinic, Limpopo Province, South Africa.
Mthembu JG; Bhuiyan M
S Afr Med J; 2021 Dec; 111(11b):1132-1135. PubMed ID: 34949236
[TBL] [Abstract][Full Text] [Related]
12. Drivers of disparities in stage at diagnosis among women with breast cancer: South African breast cancers and HIV outcomes cohort.
Mapanga W; Norris SA; Craig A; Ayeni OA; Chen WC; Jacobson JS; Neugut AI; Ruff P; Cubasch H; O'Neil DS; Buccimazza I; Čačala S; Stopforth LW; Farrow HA; Nietz S; Phakathi B; Chirwa T; McCormack VA; Joffe M
PLoS One; 2023; 18(2):e0281916. PubMed ID: 36795733
[TBL] [Abstract][Full Text] [Related]
13. Molecular breast cancer subtypes prevalence in an indigenous Sub Saharan African population.
Galukande M; Wabinga H; Mirembe F; Karamagi C; Asea A
Pan Afr Med J; 2014; 17():249. PubMed ID: 25309649
[TBL] [Abstract][Full Text] [Related]
14. Is breast cancer from Sub Saharan Africa truly receptor poor? Prevalence of ER/PR/HER2 in breast cancer from Kenya.
Sayed S; Moloo Z; Wasike R; Bird P; Oigara R; Govender D; Kibera J; Carrara H; Saleh M
Breast; 2014 Oct; 23(5):591-6. PubMed ID: 25012047
[TBL] [Abstract][Full Text] [Related]
15. Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival.
Kwan ML; Bernard PS; Kroenke CH; Factor RE; Habel LA; Weltzien EK; Castillo A; Gunderson EP; Maxfield KS; Stijleman IJ; Langholz BM; Quesenberry CP; Kushi LH; Sweeney C; Caan BJ
J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25921910
[TBL] [Abstract][Full Text] [Related]
16. Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis.
Di Meglio A; Freedman RA; Lin NU; Barry WT; Metzger-Filho O; Keating NL; King TA; Sertoli MR; Boccardo F; Winer EP; Vaz-Luis I
Breast Cancer Res Treat; 2016 Jun; 157(3):587-96. PubMed ID: 27271765
[TBL] [Abstract][Full Text] [Related]
17. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of comorbidities in women with and without breast cancer in Soweto, South Africa: Results from the SABC study.
Ayeni OA; Joffe M; Cubasch H; Rinaldi S; Taljaard C; Vorster E; Romieu I; Norris SA
S Afr Med J; 2019 Mar; 109(4):264-271. PubMed ID: 31084693
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and treatment of human epidermal growth factor receptor 2 positive breast cancer: 43,485 cases from the National Cancer Database treated in 2010 and 2011.
Killelea BK; Chagpar AB; Horowitz NR; Lannin DR
Am J Surg; 2017 Feb; 213(2):426-432. PubMed ID: 27769548
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer in Ethiopia: evidence for geographic difference in the distribution of molecular subtypes in Africa.
Hadgu E; Seifu D; Tigneh W; Bokretsion Y; Bekele A; Abebe M; Sollie T; Merajver SD; Karlsson C; Karlsson MG
BMC Womens Health; 2018 Feb; 18(1):40. PubMed ID: 29444670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
